High-dose ascorbic acid may precipitate hemolytic anemia in individuals with G6PD deficiency
This will allow air bubbles to collect at the top
They are discussed for overlapping reasons, but they come from different biological concepts, are studied through different mechanisms, and raise different safety and regulatory questions
On the evidence question: The absence of Phase III human trial data for compounds like BPC-157 and TB-500 is a genuine clinical limitation, not a technicality
Solutions: Rotate injection sites more frequently Use new needle every time Clean site thoroughly with alcohol Let alcohol dry before injecting If persistent, reduce dose or switch to oral Usually harmless: Minor reactions common Should resolve within hours to days Not dangerous unless signs of infection (warmth, spreading redness, fever) No results after 4 weeks Problem: Not seeing expected healing or improvements
Some users find lower doses perfectly adequate while others benefit from the higher end of the range
